Cellectar Makes $8M Public Offering
Cellectar Biosciences today announced the effective price of $1.50 per share of common stock of an underwritten public offering to raise approximately $8 million. According to a release, Cellectar will use…
Category Archives: Biotech
MVI Vaccine Shows ‘Promise’ vs. Cancer
Madison Vaccines Incorporated (MVI) announced today it will present data at the Society for Immunotherapy of Cancer’s Annual Meeting on Nov. 11 in National Harbor, Md., that has “promise” to stimulate an immune…
Propeller Gets 8th FDA Clearance
Propeller Health received clearance from the U.S. Food and Drug Administration on its Propeller platform for use with GlaxoSmithKline’s Ellipta inhaler, the company announced today. “Today, we are pleased to announce…
Regenerative Meds Company Launches
JangoBio recently announced its founding as a biotech company focused on restoring hormones to their optimal youthful levels. The pre-clinical stage company was formed in 2015 and is developing new therapies to sustainably…
Propeller Health Closes $21.5M Series C
Propeller Health announced today that it completed a $21.5 million Series C financing round. According to a release, the funds will be used to expand the company’s digitally guided therapy…
Cologuard’s Coverage Expands
Exact Sciences’ Cologuard continues to expand its coverage as it is now included under TRICARE’s preventive services policies, the company announced today. TRICARE provides benefits to 9.4 million active-duty, reserve and…
Cologuard Included in 2017 HEDIS
Exact Sciences’ Cologuard is now included in the 2017 Healthcare Effectiveness Data and Information Set (HEDIS) quality measures for colorectal cancer screening, the organization announced recently. “Cologuard’s inclusion in the…
SHINE to Move HQ to Janesville
SHINE Medical Technologies announced this week that it is moving its headquarters from Monona, Wis., to Janesville, Wis., later this year. According to a release, all of SHINE’s employees will…
UW Study to Use Cellectar Compound
Cellectar Biosciences’ CLR 131, its lead therapeutic compound, will be used in a University of Wisconsin study of neck and head cancers, the organization announced today. According to a release,…
CDI Creates Business Divisions
Cellular Dynamics International announced today that it has created Therapeutics and Life Science business units to better serve its customers. “CDI and Fujifilm are firmly committed to the long-term potential of…
